Followers | 15 |
Posts | 2103 |
Boards Moderated | 0 |
Alias Born | 07/01/2016 |
Wednesday, August 29, 2018 1:36:24 PM
http://www.premierbiomedical.com/
https://painreliefmeds.com/
http://www.thestreetnow.com/spotlight/biei/
https://twitter.com/PremierBiomedic
https://twitter.com/bieiotc?lang=de
https://www.facebook.com/Premier-Biomedical-Pain-Relief-Meds-332858840514123/
1.
8 hemp oil / CBD based pain relief products:
First revenues after initial delays:
http://www.premierbiomedical.com/premier-biomedical-ceo-update-letter-july-2018/
Sale among others here:
https://painreliefmeds.com/shop/
https://www.healthwarehouse.com/solr/result/?q=Premier+Biomedical
2.
Patent-pending anti-aging process utilizing Premier Biomedical’s patented process to remove the physiologic basis of aging:
http://www.premierbiomedical.com/anti-aging-patent-application-filed-exclusive-commercial-rights-to-premier-biomedical-inc/
3.
Patent-pending anti-breast cancer drug that outperformed chemo and the leading competitive breast cancer drug in animal tests
4.
Patented process to treat and cure PTSD/ Chronic Traumatic Encephalopathy (CTE)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139303411
The firm has exceptional privileges to three dispensed patents, one provisional patent application and six pending applications, all related to unique treatments for cancer as well as extracorporeal treatments for different life-threatening ailments.
Research programme: extracorporeal antibody therapies - Premier Biomedical
https://adisinsight.springer.com/drugs/800039542
Research programme: low dose naltrexone-based therapeutic - Premier Biomedical
https://adisinsight.springer.com/drugs/800039614
Further information:
Overview, Quote, Company Profile, Security Details, News, Financials, Disclosure
https://www.otcmarkets.com/stock/BIEI/research
Newsroom
http://www.premierbiomedical.com/newsroom/
CEO UPDATE LETTER (every quarter of a year) — JULY, 2018
http://www.premierbiomedical.com/premier-biomedical-ceo-update-letter-july-2018/
Videos
vimeo Premier Biomedical Inc.
https://www.google.de/search?ei=rhODW9_SE8zLwAL9sbTAAQ&q=vimeo+Premier+Biomedical+Inc.&oq=vimeo+Premier+Biomedical+Inc.&gs_l=psy-ab.12...28148.29838.0.31936.2.2.0.0.0.0.82.144.2.2.0....0...1.1j2.64.psy-ab..0.0.0....0.D5n6B9HJo_k
youtube Premier Biomedical Inc.
Interviews
MONEY TV – last
https://vimeo.com/286450462
Uptick Newswire’s “Stock Day” – last
http://upticknewswire.com/featured-interview-ceo-william-hartman-of-premier-biomedical-inc-otcqb-biei-9/
Press
Intellectual property – patents
http://www.premierbiomedical.com/science/intellectual-property/
Cancer
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/cancer/
Blood Sepsis and Viremia
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/blood-sepsis-and-viremia/
Fibromyalgia
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/fibromyalgia/
Multiple Sclerosis (MS)
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/multiple-sclerosis-ms/
Contact
Send all correspondence to our business office:
PO Box 25
Jackson Center, PA 16133
Phone :
(724) 633-7033
(PBI) MED-7033
Email : info@premierbiomedical.com
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM